India approves first dengue vaccine for 4-60 age group
The story in brief
India approved its first dengue vaccine, QDENGA, for individuals aged 4 to 60 years, marking a major step in combating the country’s rising dengue burden. The vaccine, developed by Takeda, has been approved in 43 countries and is recommended by the WHO for use without pre-vaccination screening. India accounts for nearly 34% of global dengue cases, with reported cases rising 11-fold over two decades.